1
|
Piccione PM, Lang MN, Amado Becker F, Hofstetter A, Marchal S, Ly K, Legras V, Ewert A, Kohler D, Maurer R, Willecke N, Burwood R, Kroll P. Computer-Aided formulation design for pharmaceutical drug product development, part 01: Materials exploration through a visualization tool. Int J Pharm 2024; 667:124891. [PMID: 39481812 DOI: 10.1016/j.ijpharm.2024.124891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2024] [Revised: 10/27/2024] [Accepted: 10/28/2024] [Indexed: 11/03/2024]
Abstract
An interactive tool has been developed to help design oral solid dosage form formulations. The tool enables quantitative explorations and comparisons of physical, bulk, and mechanical properties, and takes into account functional characteristics as well. In this manner, comparisons and clustering of both excipients and APIs can be carried out. These comparisons enable the generation of alternatives as well as surrogate identification, so as to spare resources and material. Multiple data sources were merged to create a "joint" data table with all relevant properties. Four main workflow activities are supported: Explore Materials, Search Similar APIs, Search Similar Excipients and Search Material Clusters. Multi-dimensional filtering can be superimposed to each functionality. Suggested visualizations are made particularly accessible by providing them as "standard plots". The underlying philosophy is to empower formulation scientists to explore options, rather than prescribe decisions on exclusively mathematical grounds. The tool described here is the first step towards a holistic optimization incorporating predictions of mixture properties. Methodology of use is illustrated through three material selection application examples.
Collapse
Affiliation(s)
- Patrick M Piccione
- F. Hoffmann-La Roche AG, 4070 Basel, Switzerland; dsm-firmenich, Route de la Plaine 125, 1283 La Plaine, Switzerland.
| | - Moritz N Lang
- F. Hoffmann-La Roche AG, 4070 Basel, Switzerland; Roche Diagnostics GmbH, 82377 Penzberg, Germany
| | | | | | | | - Kevin Ly
- F. Hoffmann-La Roche AG, 4070 Basel, Switzerland; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
| | | | | | - David Kohler
- F. Hoffmann-La Roche AG, 4070 Basel, Switzerland
| | - Reto Maurer
- F. Hoffmann-La Roche AG, 4070 Basel, Switzerland
| | | | - Ryan Burwood
- F. Hoffmann-La Roche AG, 4070 Basel, Switzerland
| | - Paul Kroll
- F. Hoffmann-La Roche AG, 4070 Basel, Switzerland; Muvon Therapeutics AG, 8092 Zürich, Switzerland
| |
Collapse
|
2
|
Schneider P, Maus M, Paul S, Wagner KG. Powder dosing within continuous manufacturing: A lean approach for gravimetric dosing configuration and equipment selection. Int J Pharm 2024; 667:124903. [PMID: 39522835 DOI: 10.1016/j.ijpharm.2024.124903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2024] [Revised: 10/28/2024] [Accepted: 11/01/2024] [Indexed: 11/16/2024]
Abstract
This work presents a novel approach to select gravimetric dosing configurations for continuous unit operations in pharmaceutical processing. It optimizes material, time, and personnel use, and allows selections for configurations of materials not included in the model by robust material attribute-based interpolation. The approach does not apply Principal Component Analysis (PCA) and Partial Least Squares (PLS). Instead, a reduced set of material attributes that require measurement was determined from existing material attribute libraries found in literature. Only those identified 17 attributes were measured for 13 materials and employed in this study. The established model proved to be predictive for an even further reduced attribute set of 12 attributes. The model introduces a simplified method for selecting feeding equipment combining precision metrics (relative mean intra-bin variability) and model parameters (fmax, fmin, β). The reduction of Material Attributes (MAs) in this short-cut method enables fast evaluation and enhances resource efficiency by incorporating only a few selected MAs into the model and therefore introduces a different line of thinking. It was also possible to compare feeding of different hopper geometries, showing that flat bottom-hoppers have higher dosing precision than round bottom-hoppers. In conclusion, this work introduces a smart and innovative model that simplifies the equipment selection process and brings objectivity through a comprehensive numerical description of the discharge characteristics, and provides new options for continuous dosing in pharma through combining precision and curve fitting parameters.
Collapse
Affiliation(s)
- Petra Schneider
- Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany; Department of Pharmaceutical Technology, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany
| | - Martin Maus
- Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany
| | - Shubhajit Paul
- Material and Analytical Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 900 Ridgebury Rd, Ridgefield, CT 06877, United States
| | - Karl G Wagner
- Department of Pharmaceutical Technology, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany.
| |
Collapse
|
3
|
He X, Li J, Wen X, Ma S, An Y, Zhang X, Guan J, Mao S. Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation. Int J Pharm 2024; 664:124609. [PMID: 39163928 DOI: 10.1016/j.ijpharm.2024.124609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Revised: 07/26/2024] [Accepted: 08/16/2024] [Indexed: 08/22/2024]
Abstract
Magnesium stearate (MgSt) and lactose fines are often used as ternary components in carrier-based dry powder inhalers (DPIs) to improve fine particle fraction (FPF), but whether they act synergistically to improve aerosolization performance of DPI formulations is currently less studied. In addition, the applicability of utilizing powder rheological parameters to predict the FPF needs to be further verified. Thus, in this study, using fluticasone propionate (FP) as a model drug, effect of lactose fines addition in 0.5% MgSt containing DPI formulations on their powder and aerodynamic properties was explored. Influence of MgSt and fines mixing order on the DPIs performance was also investigated. The results showed that addition of lactose fines (1-10%) in 0.5% MgSt containing formulations could further improve flowability and enhance adhesion of the mixtures, and they could act synergistically to improve FPF. Moreover, the presence of 0.5% MgSt can greatly reduce the amount of lactose fines required to achieve the comparable FPF. The mixing order can affect distribution of MgSt on the carrier surface, with higher FPF noted when MgSt was mixed with carrier first, followed by lactose fines. A good linear relationship between powder rheological parameters such as basic flowability energy (BFE), Permeability and FPF was disclosed. In conclusion, in FP based DPIs, MgSt and lactose fines act synergistically to enhance FPF by tuning powder characteristics. Good flowability (27.39%) and strong adhesion (72.61%) contributed to the enhanced drug deposition in the lung.
Collapse
Affiliation(s)
- Xianhong He
- School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Jiayi Li
- School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Xiangce Wen
- School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Sibo Ma
- School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Yalin An
- School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China
| | - Xin Zhang
- School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China
| | - Jian Guan
- School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China
| | - Shirui Mao
- School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China.
| |
Collapse
|
4
|
Kobayashi Y, Kim S, Nagato T, Oishi T, Kano M. Feed factor profile prediction model for two-component mixed powder in the twin-screw feeder. Int J Pharm X 2024; 7:100242. [PMID: 38601059 PMCID: PMC11004622 DOI: 10.1016/j.ijpx.2024.100242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2023] [Revised: 03/14/2024] [Accepted: 03/28/2024] [Indexed: 04/12/2024] Open
Abstract
In continuous pharmaceutical manufacturing processes, it is crucial to control the powder flow rate. The feeding process is characterized by the amount of powder delivered per screw rotation, referred to as the feed factor. This study aims to develop models for predicting the feed factor profiles (FFPs) of two-component mixed powders with various formulations, while most previous studies have focused on single-component powders. It further aims to identify the suitable model type and to determine the significance of material properties in enhancing prediction accuracy by using several FFP prediction models with different input variables. Four datasets from the experiment were generated with different ranges of the mass fraction of active pharmaceutical ingredients (API) and the powder weight in the hopper. The candidates for the model inputs are (a) the mass fraction of API, (b) process parameters, and (c) material properties. It is desirable to construct a high-performance prediction model without the material properties because their measurement is laborious. The results show that using (c) as input variables did not improve the prediction accuracy as much, thus there is no need to use them.
Collapse
Affiliation(s)
- Yuki Kobayashi
- Department of Systems Science, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto 6068501, Kyoto, Japan
| | - Sanghong Kim
- Department of Applied Physics and Chemical Engineering, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, 1840012 Tokyo, Japan
| | - Takuya Nagato
- Research and Development Division, Powrex Corporation, 5-5-5 Kitagawara, Itami 6640837, Hyogo, Japan
| | - Takuya Oishi
- Research and Development Division, Powrex Corporation, 5-5-5 Kitagawara, Itami 6640837, Hyogo, Japan
- Department of Applied Chemistry, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, 1840012 Tokyo, Japan
| | - Manabu Kano
- Department of Systems Science, Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto 6068501, Kyoto, Japan
| |
Collapse
|
5
|
Bhalode P, Razavi SM, Tian H, Roman-Ospino A, Scicolone J, Callegari G, Dubey A, Koolivand A, Krull S, O'Connor T, Muzzio FJ, Ierapetritou MG. Statistical data treatment for residence time distribution studies in pharmaceutical manufacturing. Int J Pharm 2024; 657:124133. [PMID: 38642620 DOI: 10.1016/j.ijpharm.2024.124133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2024] [Revised: 04/13/2024] [Accepted: 04/15/2024] [Indexed: 04/22/2024]
Abstract
Residence time distribution (RTD) method has been widely used in the pharmaceutical manufacturing for understanding powder dynamics within unit operations and continuous integrated manufacturing lines. The dynamics thus captured is then used to develop predictive models for unit operations and important RTD-based applications ensuring product quality assurance. Despite thorough efforts in tracer selection, data acquisition, and calibration model development to obtain tracer concentration profiles for RTD studies, there can exist significant noise in these profiles. This noise can make it challenging to identify the underlying signal and get a representative RTD of the system under study. Such concerns have previously indicated the importance of noise handling for RTD measurements in literature. However, the literature does not provide sufficient information on noise handling or data treatment strategies for RTD studies. To this end, we investigate the impact of varying levels of noise using different tracers on measurement of RTD profile and its applications. We quantify the impact of different denoising methods (time and frequency averaging methods). Through this investigation, we see that Savitsky Golay filtering turns out to a good method for denoising RTD profiles despite varying noise levels. The investigation is performed such that the key features of the RTD profile (which are important for RTD based applications) are preserved. Subsequently, we also investigate the impact of denoising on RTD-based applications such as out-of-specification (OOS) analysis and RTD modeling. The results show that the degree of noise levels considered in this work do not significantly impact the RTD-based applications.
Collapse
Affiliation(s)
- Pooja Bhalode
- Center of Plastics Innovation, University of Delaware, DE, USA
| | - Sonia M Razavi
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | - Huayu Tian
- Department of Chemical and Biomolecular Engineering, University of Delaware, DE, USA
| | - Andres Roman-Ospino
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | - James Scicolone
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | - Gerardo Callegari
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | - Atul Dubey
- Pharmaceutical Continuous Manufacturing (PCM), United States Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD, USA
| | - Abdollah Koolivand
- Office of Pharmaceutical Quality, Center for Drug Evaluation Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Springs, MD 20993, USA
| | - Scott Krull
- Office of Pharmaceutical Quality, Center for Drug Evaluation Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Springs, MD 20993, USA
| | - Thomas O'Connor
- Office of Pharmaceutical Quality, Center for Drug Evaluation Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Springs, MD 20993, USA
| | - Fernando J Muzzio
- Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
| | | |
Collapse
|
6
|
Iwata H, Hayashi Y, Koyama T, Hasegawa A, Ohgi K, Kobayashi I, Okuno Y. Feature extraction of particle morphologies of pharmaceutical excipients from scanning electron microscope images using convolutional neural networks. Int J Pharm 2024; 653:123873. [PMID: 38336179 DOI: 10.1016/j.ijpharm.2024.123873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Revised: 01/08/2024] [Accepted: 01/30/2024] [Indexed: 02/12/2024]
Abstract
Scanning electron microscopy (SEM) images are the most widely used tool for evaluating particle morphology; however, quantitative evaluation using SEM images is time-consuming and often neglected. In this study, we aimed to extract features related to particle morphology of pharmaceutical excipients from SEM images using a convolutional neural network (CNN). SEM images of 67 excipients were acquired and used as models. A classification CNN model of the excipients was constructed based on the SEM images. Further, features were extracted from the middle layer of this CNN model, and the data was compressed to two dimensions using uniform manifold approximation and projection. Lastly, hierarchical clustering analysis (HCA) was performed to categorize the excipients into several clusters and identify similarities among the samples. The classification CNN model showed high accuracy, allowing each excipient to be identified with a high degree of accuracy. HCA revealed that the 67 excipients were classified into seven clusters. Additionally, the particle morphologies of excipients belonging to the same cluster were found to be very similar. These results suggest that CNN models are useful tools for extracting information and identifying similarities among the particle morphologies of excipients.
Collapse
Affiliation(s)
- Hiroaki Iwata
- Graduate School of Medicine, Kyoto University, 53 Shogoin-kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan.
| | - Yoshihiro Hayashi
- Graduate School of Medicine, Kyoto University, 53 Shogoin-kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan; Pharmaceutical Technology Management Department, Production Division, Nichi-Iko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa Namerikawa-shi, Toyama 936-0857, Japan.
| | - Takuto Koyama
- Graduate School of Medicine, Kyoto University, 53 Shogoin-kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan
| | - Aki Hasegawa
- Graduate School of Medicine, Kyoto University, 53 Shogoin-kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan
| | - Kosuke Ohgi
- Formulation Development Department, Development & Planning Division, Nichi-Iko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa Namerikawa-shi, Toyama 936-0857, Japan
| | - Ippei Kobayashi
- Formulation Development Department, Development & Planning Division, Nichi-Iko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa Namerikawa-shi, Toyama 936-0857, Japan
| | - Yasushi Okuno
- Graduate School of Medicine, Kyoto University, 53 Shogoin-kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan; RIKEN Center for Computational Science, Kobe 650-0047, Japan
| |
Collapse
|
7
|
Cao J, Shen H, Zhao S, Ma X, Chen L, Dai S, Xu B, Qiao Y. Sample Size Requirements of a Pharmaceutical Material Library: A Case in Predicting Direct Compression Tablet Tensile Strength by Latent Variable Modeling. Pharmaceutics 2024; 16:242. [PMID: 38399296 PMCID: PMC10893091 DOI: 10.3390/pharmaceutics16020242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 01/26/2024] [Accepted: 01/31/2024] [Indexed: 02/25/2024] Open
Abstract
The material library is an emerging, new data-driven approach for developing pharmaceutical process models. How many materials or samples should be involved in a particular application scenario is unclear, and the impact of sample size on process modeling is worth discussing. In this work, the direct compression process was taken as the research object, and the effects of different sample sizes of material libraries on partial least squares (PLS) modeling in the prediction of tablet tensile strength were investigated. A primary material library comprising 45 materials was built. Then, material subsets containing 5 × i (i = 1, 2, 3, …, 8) materials were sampled from the primary material library. Each subset underwent sampling 1000 times to analyze variations in model fitting performance. Both hierarchical sampling and random sampling were employed and compared, with hierarchical sampling implemented with the help of the tabletability classification index d. For each subset, modeling data were organized, incorporating 18 physical properties and tableting pressure as the independent variables and tablet tensile strength as the dependent variable. A series of chemometric indicators was used to assess model performance and find important materials for model training. It was found that the minimum R2 and RMSE values reached their maximum, and the corresponding values were kept almost unchanged when the sample sizes varied from 20 to 45. When the sample size was smaller than 15, the hierarchical sampling method was more reliable in avoiding low-quality few-shot PLS models than the random sampling method. Two important materials were identified as useful for building an initial material library. Overall, this work demonstrated that as the number of materials increased, the model's reliability improved. It also highlighted the potential for effective few-shot modeling on a small material library by controlling its information richness.
Collapse
Affiliation(s)
- Junjie Cao
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Haoran Shen
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
| | - Shuying Zhao
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Xiao Ma
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Liping Chen
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Shengyun Dai
- National Institutes for Food and Drug Control, Beijing 100050, China;
| | - Bing Xu
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Yanjiang Qiao
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| |
Collapse
|
8
|
Sierra-Vega NO, Alsharif FM, O'Connor T, Ashraf M, Zidan A. Characterizing a design space for a twin-screw wet granulation process: A case study of extended-release tablets. Int J Pharm 2024; 650:123681. [PMID: 38070661 DOI: 10.1016/j.ijpharm.2023.123681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 11/27/2023] [Accepted: 12/04/2023] [Indexed: 01/08/2024]
Abstract
Twin-screw wet granulation is an emerging continuous manufacturing technology for solid oral dosage forms. This technology has been successfully employed for the commercial manufacture of immediate-released tablets. However, the higher polymer content in extended-release (ER) formulations may present challenges in developing and operating within a desired design space. The work described here used a systematic approach for defining the optimum design space by understanding the effects of the screw design, operating parameters, and their interactions on the critical characteristics of granules and ER tablets. The impacts of screw speed, powder feeding rate, and the number of kneading (KEs) and sizing elements on granules and tablets characteristics were investigated by employing a definitive screening design. A semi-mechanistic model was used to calculate the residence time distribution parameters and validated using the tracers. The results showed that an increase in screw speed decreased the mean residence time of the material within the barrel, while an increase in the powder feeding rate or number of KEs did the opposite and increased the barrel residence time. Screw design and operating parameters affected the flow and bulk characteristics of granules. The screw speed was the most significant factor impacting the tablet's breaking strength. The dissolution profiles revealed that granule characteristics mainly influenced the early phase of drug release. This study demonstrated that a simultaneous optimization of both operating and screw design parameters was beneficial in producing ER granules and tablets of desired performance characteristics while mitigating any failure risks, such as swelling during processing.
Collapse
Affiliation(s)
- Nobel O Sierra-Vega
- Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20903, USA
| | - Fahd M Alsharif
- Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20903, USA
| | - Thomas O'Connor
- Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20903, USA
| | - Muhammad Ashraf
- Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20903, USA
| | - Ahmed Zidan
- Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20903, USA.
| |
Collapse
|
9
|
Su J, Zhang K, Qi F, Cao J, Miao Y, Zhang Z, Qiao Y, Xu B. A tabletability change classification system in supporting the tablet formulation design via the roll compaction and dry granulation process. Int J Pharm X 2023; 6:100204. [PMID: 37560487 PMCID: PMC10407897 DOI: 10.1016/j.ijpx.2023.100204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 07/26/2023] [Accepted: 07/27/2023] [Indexed: 08/11/2023] Open
Abstract
In this paper, the material library approach was used to uncover the pattern of tabletability change and related risk for tablet formulation design under the roll compaction and dry granulation (RCDG) process. 31 materials were fully characterized using 18 physical parameters and 9 compression behavior classification system (CBCS) parameters. Then, each material was dry granulated and sieved into small granules (125-250 μm) and large granules (630-850 μm), respectively. The compression behavior of granules was characterized by the CBCS descriptors, and were compared with that of ungranulated powders. The relative change of tabletability (CoTr) index was used to establish the tabletability change classification system (TCCS), and all materials were classified into three types, i.e. loss of tabletability (LoT, Type I), unchanged tabletability (Type II) and increase of tabletability (Type III). Results showed that approximately 65% of materials presented LoT, and as the granules size increased, 84% of the materials exhibited LoT. A risk decision tree was innovatively proposed by joint application of the CBCS tabletability categories and the TCCS tabletability change types. It was found that the LoT posed little risk to the tensile strength of the final tablet, when Category 1 or 2A materials, or Category 2B materials with Type II or Type III change of tabletability were used. Formulation risk happened to Category 2C or 3 materials, or Category 2B materials with Type I change of tabletability, particularly when high proportions of these materials were involved in tablet formulation. In addition, the risk assessment results were verified in the material property design space developed from a latent variable model in prediction of tablet tensile strength. Overall, results suggested that a combinational use of CBCS and TCCS could aid the decision making in selecting materials for tablet formulation design via RCDG.
Collapse
Affiliation(s)
- Junhui Su
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| | - Kunfeng Zhang
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Feiyu Qi
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Junjie Cao
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Yuhua Miao
- The International Department, No. 8 Middle School of Beijing, Beijing 100045, PR China
| | - Zhiqiang Zhang
- Beijing Tcmages Pharmceutical Co. LTD, Beijing 101301, PR China
| | - Yanjiang Qiao
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| | - Bing Xu
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| |
Collapse
|
10
|
Continuous Feeding and Blending Demonstration with Co-Processed Drug Substance. J Pharm Sci 2022:S0022-3549(22)00535-4. [DOI: 10.1016/j.xphs.2022.11.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Revised: 11/22/2022] [Accepted: 11/22/2022] [Indexed: 12/05/2022]
|
11
|
Using a Material Library to Understand the Change of Tabletability by High Shear Wet Granulation. Pharmaceutics 2022; 14:pharmaceutics14122631. [PMID: 36559125 PMCID: PMC9783360 DOI: 10.3390/pharmaceutics14122631] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Revised: 11/16/2022] [Accepted: 11/23/2022] [Indexed: 11/29/2022] Open
Abstract
Understanding the tabletability change of materials after granulation is critical for the formulation and process design in tablet development. In this paper, a material library consisting of 30 pharmaceutical materials was used to summarize the pattern of change of tabletability during high shear wet granulation and tableting (HSWGT). Each powdered material and the corresponding granules were characterized by 19 physical properties and nine compression behavior classification system (CBCS) parameters. Principal component analysis (PCA) was used to compare the physical properties and compression behaviors of ungranulated powders and granules. A new index, namely the relative change of tabletability (CoTr), was proposed to quantify the tabletability change, and its advantages over the reworking potential were demonstrated. On the basis of CoTr values, the tabletability change classification system (TCCS) was established. It was found that approximately 40% of materials in the material library presented a loss of tabletability (i.e., Type I), 50% of materials had nearly unchanged tabletability (i.e., Type II), and 10% of materials suffered from increased tabletability (i.e., Type III). With the help of tensile strength (TS) vs. compression pressure curves implemented on both powders and granules, a data fusion method and the PLS2 algorithm were further applied to identify the differences in material properties requirements for direct compression (DC) and HSWGT. Results indicated that increasing the plasticity or porosity of the starting materials was beneficial to acquiring high TS of tablets made by HSWGT. In conclusion, the presented TCCS provided a means for the initial risk assessment of materials in tablet formulation design and the data modeling method helped to predict the impact of formulation ingredients on the strength of compacts.
Collapse
|
12
|
Predicting powder feedability: A workflow for assessing the risk of flow stagnation and defining the operating space for different powder-feeder combinations. Int J Pharm 2022; 629:122364. [DOI: 10.1016/j.ijpharm.2022.122364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2022] [Revised: 10/28/2022] [Accepted: 10/30/2022] [Indexed: 11/06/2022]
|
13
|
A Multivariate Methodology for Material Sparing Characterization and Blend Design in Drug Product Development. Int J Pharm 2022; 621:121801. [DOI: 10.1016/j.ijpharm.2022.121801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Revised: 04/28/2022] [Accepted: 04/30/2022] [Indexed: 11/20/2022]
|
14
|
Johnson BJ, Sen M, Hanson J, García-Muñoz S, Sahinidis NV. Stochastic analysis and modeling of pharmaceutical screw feeder mass flow rates. Int J Pharm 2022; 621:121776. [DOI: 10.1016/j.ijpharm.2022.121776] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Revised: 04/16/2022] [Accepted: 04/24/2022] [Indexed: 11/27/2022]
|
15
|
Sánchez-Paternina A, Martínez-Cartagena P, Li J, Scicolone J, Singh R, Lugo YC, Romañach RJ, Muzzio FJ, Román-Ospino AD. Residence time distribution as a traceability method for lot changes in a pharmaceutical continuous manufacturing system. Int J Pharm 2022; 611:121313. [PMID: 34822965 DOI: 10.1016/j.ijpharm.2021.121313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Revised: 11/03/2021] [Accepted: 11/19/2021] [Indexed: 02/03/2023]
Abstract
Residence time distribution (RTD) models were developed to track raw material lots and investigate batch transitions in a continuous manufacturing system. Two raw materials with similar physical properties (granular metformin and lactose) were identified via Principal Component Analysis (PCA) from a library of bulk material properties and used to simulate the switching of lots during production. In-line near-infrared (NIR) spectra were collected with the powder flowing through a chute in a continuous manufacturing system to monitor metformin and lactose concentration in step-change experiments with Partial Least Squares (PLS) models. RTD provided an understanding of raw material propagation through the continuous manufacturing system. Transition times between raw material changes were identified using the results of two multivariate approaches PLS and PCA. The methodology was implemented to discriminate the transition zone in a raw material change, contributing to design control strategies for acceptance and diverting mechanisms.
Collapse
Affiliation(s)
- Adriluz Sánchez-Paternina
- Center for Structured Organic Particulate Systems (C-SOPS), Department of Chemistry, University of Puerto Rico Mayaguez Campus, PO Box 9000, Mayaguez, PR 00681, Puerto Rico
| | - Pedro Martínez-Cartagena
- Center for Structured Organic Particulate Systems (C-SOPS), Department of Chemistry, University of Puerto Rico Mayaguez Campus, PO Box 9000, Mayaguez, PR 00681, Puerto Rico
| | - Jingzhe Li
- Center for Structured Organic Particulate Systems (C-SOPS), Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| | - James Scicolone
- Center for Structured Organic Particulate Systems (C-SOPS), Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Ravendra Singh
- Center for Structured Organic Particulate Systems (C-SOPS), Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Yleana C Lugo
- Janssen Supply Chain, Johnson & Johnson, Gurabo, Puerto Rico
| | - Rodolfo J Romañach
- Center for Structured Organic Particulate Systems (C-SOPS), Department of Chemistry, University of Puerto Rico Mayaguez Campus, PO Box 9000, Mayaguez, PR 00681, Puerto Rico
| | - Fernando J Muzzio
- Center for Structured Organic Particulate Systems (C-SOPS), Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Andrés D Román-Ospino
- Center for Structured Organic Particulate Systems (C-SOPS), Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
| |
Collapse
|
16
|
Bhalode P, Tian H, Gupta S, Razavi SM, Roman-Ospino A, Talebian S, Singh R, Scicolone JV, Muzzio FJ, Ierapetritou M. Using residence time distribution in pharmaceutical solid dose manufacturing - A critical review. Int J Pharm 2021; 610:121248. [PMID: 34748808 DOI: 10.1016/j.ijpharm.2021.121248] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Revised: 10/04/2021] [Accepted: 10/27/2021] [Indexed: 11/18/2022]
Abstract
While continuous manufacturing (CM) of pharmaceutical solid-based drug products has been shown to be advantageous for improving the product quality and process efficiency in alignment with FDA's support of the quality-by-design paradigm (Lee, 2015; Ierapetritou et al., 2016; Plumb, 2005; Schaber, 2011), it is critical to enable full utilization of CM technology for robust production and commercialization (Schaber, 2011; Byrn, 2015). To do so, an important prerequisite is to obtain a detailed understanding of overall process characteristics to develop cost-effective and accurate predictive models for unit operations and process flowsheets. These models are utilized to predict product quality and maintain desired manufacturing efficiency (Ierapetritou et al., 2016). Residence time distribution (RTD) has been a widely used tool to characterize the extent of mixing in pharmaceutical unit operations (Vanhoorne, 2020; Rogers and Ierapetritou, 2015; Teżyk et al., 2015) and manufacturing lines and develop computationally cheap predictive models. These models developed using RTD have been demonstrated to be crucial for various flowsheet applications (Kruisz, 2017; Martinetz, 2018; Tian, 2021). Though extensively used in the literature (Gao et al., 2012), the implementation, execution, evaluation, and assessment of RTD studies has not been standardized by regulatory agencies and can thus lead to ambiguity regarding their accurate implementation. To address this issue and subsequently prevent unforeseen errors in RTD implementation, the presented article aims to aid in developing standardized guidelines through a detailed review and critical discussion of RTD studies in the pharmaceutical manufacturing literature. The review article is divided into two main sections - 1) determination of RTD including different steps for RTD evaluation including experimental approach, data acquisition and pre-treatment, RTD modeling, and RTD metrics and, 2) applications of RTD for solid dose manufacturing. Critical considerations, pertaining to the limitations of RTDs for solid dose manufacturing, are also examined along with a perspective discussion of future avenues of improvement.
Collapse
Affiliation(s)
- Pooja Bhalode
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Huayu Tian
- Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA
| | - Shashwat Gupta
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Sonia M Razavi
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Andres Roman-Ospino
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Shahrzad Talebian
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Ravendra Singh
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - James V Scicolone
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Fernando J Muzzio
- Department of Chemical and Biochemical Engineering, Rutgers - The State University of New Jersey, Piscataway, NJ 08854, USA
| | - Marianthi Ierapetritou
- Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.
| |
Collapse
|
17
|
Hayashi Y, Nakano Y, Marumo Y, Kumada S, Okada K, Onuki Y. Application of machine learning to a material library for modeling of relationships between material properties and tablet properties. Int J Pharm 2021; 609:121158. [PMID: 34624447 DOI: 10.1016/j.ijpharm.2021.121158] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2021] [Revised: 09/29/2021] [Accepted: 10/01/2021] [Indexed: 10/20/2022]
Abstract
This study investigates the usefulness of machine learning for modeling complex relationships in a material library. We tested 81 types of active pharmaceutical ingredients (APIs) and their tablets to construct the library, which included the following variables: 20 types of API material properties, one type of process parameter (three levels of compression pressure), and two types of tablet properties (tensile strength (TS) and disintegration time (DT)). The machine learning algorithms boosted tree (BT) and random forest (RF) were applied to analysis of our material library to model the relationships between input variables (material properties and compression pressure) and output variables (TS and DT). The calculated BT and RF models achieved higher performance statistics compared with a conventional modeling method (i.e., partial least squares regression), and revealed the material properties that strongly influence TS and DT. For TS, true density, the tenth percentile of the cumulative percentage size distribution, loss on drying, and compression pressure were of high relative importance. For DT, total surface energy, water absorption rate, polar surface energy, and hygroscopicity had significant effects. Thus, we demonstrate that BT and RF can be used to model complex relationships and clarify important material properties in a material library.
Collapse
Affiliation(s)
- Yoshihiro Hayashi
- Pharmaceutical Technology Division, Nichi-Iko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa, Namerikawa-shi, Toyama 936-0857, Japan; Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan.
| | - Yuri Nakano
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan
| | - Yuki Marumo
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan
| | - Shungo Kumada
- Pharmaceutical Technology Division, Nichi-Iko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa, Namerikawa-shi, Toyama 936-0857, Japan
| | - Kotaro Okada
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan
| | - Yoshinori Onuki
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan
| |
Collapse
|
18
|
Effects of signal processing on the relative standard deviation in powder feeding characterization for continuous manufacturing. POWDER TECHNOL 2021. [DOI: 10.1016/j.powtec.2021.05.068] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
19
|
Wahlich J. Review: Continuous Manufacturing of Small Molecule Solid Oral Dosage Forms. Pharmaceutics 2021; 13:1311. [PMID: 34452272 PMCID: PMC8400279 DOI: 10.3390/pharmaceutics13081311] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2021] [Revised: 07/29/2021] [Accepted: 08/19/2021] [Indexed: 01/04/2023] Open
Abstract
Continuous manufacturing (CM) is defined as a process in which the input material(s) are continuously fed into and transformed, and the processed output materials are continuously removed from the system. CM can be considered as matching the FDA's so-called 'Desired State' of pharmaceutical manufacturing in the twenty-first century as discussed in their 2004 publication on 'Innovation and Continuous Improvement in Pharmaceutical Manufacturing'. Yet, focused attention on CM did not really start until 2014, and the first product manufactured by CM was only approved in 2015. This review describes some of the benefits and challenges of introducing a CM process with a particular focus on small molecule solid oral dosage forms. The review is a useful introduction for individuals wishing to learn more about CM.
Collapse
Affiliation(s)
- John Wahlich
- Academy of Pharmaceutical Sciences, c/o Bionow, Greenheys Business Centre, Manchester Science Park, Pencroft Way, Manchester M15 6JJ, UK
| |
Collapse
|
20
|
Schenck L, Neri C, Jia X, Schafer W, Axnanda S, Canfield N, Li F, Shah V. A Co-Processed API Approach for a Shear Sensitive Compound Affording Improved Chemical Stability and Streamlined Drug Product Processing. J Pharm Sci 2021; 110:3238-3245. [PMID: 34089710 DOI: 10.1016/j.xphs.2021.05.013] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Revised: 05/28/2021] [Accepted: 05/28/2021] [Indexed: 11/15/2022]
Abstract
The physical properties of active pharmaceutical ingredients (API) are critical to both drug substance (DS) isolation and drying operations, as well as streamlined drug product (DP) processing and the quality of final dosage units. High aspect ratio, low bulk density, API 'needles' in particular are a hindrance to efficient processing, with a low probability that conventional crystallization routes can modify the challenging morphology. The compound evaluated in this manuscript demonstrated this non-ideal morphology, with the added complexity of shear sensitivity. Modest shear exposure resulted in conversion of the thermodynamically stable crystalline phase to the amorphous phase, with the amorphous phase then undergoing accelerated chemical degradation. Slow filtration during DS isolation resulted in uncontrolled and elevated amorphous levels, while subsequent DP operations including blending, densification and compression increased amorphous content still further. A chemically stable final dosage unit would ideally involve a high bulk density, free flowing API that did not require densification in order to be commercialized as an oral dosage form with direct encapsulation of a single dosage unit. Despite every effort to modify the crystallization process, the physical properties of the API could not be improved. Here, an innovative isolation strategy using a thin film evaporation (TFE) process in the presence of a water soluble polymer alleviated filtration and drying risks and consistently achieved a high bulk density, free flowing co-processed API amenable to direct encapsulation. Characterization of the engineered materials suggested the lower amorphous levels and reduced shear sensitivity were achieved by coating surfaces of the API at relatively low polymer loads. This particle engineering route blurred conventional DS/DP boundaries that not only achieved improved chemical stability but also resulted in a optimized material, with simplified and more robust processing operations for both drug substance and drug product.
Collapse
Affiliation(s)
- Luke Schenck
- Process Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA.
| | - Claudia Neri
- Analytical Sciences, Pharmaceutical Sciences, Merck & Co., Inc., Kenilworth, NJ, USA.
| | - Xiujuan Jia
- Analytical Sciences, Pharmaceutical Sciences, Merck & Co., Inc., Kenilworth, NJ, USA
| | - Wes Schafer
- Process Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA
| | - Stephanus Axnanda
- Process Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA
| | - Nicole Canfield
- Preformulation, Pharmaceutical Sciences, Merck & Co., Inc., Kenilworth, NJ, USA
| | - Feng Li
- Oral Formulation Sciences, Pharmaceutical Sciences, Merck & Co., Inc., Kenilworth, NJ, USA
| | - Vivek Shah
- Analytical Sciences, Pharmaceutical Sciences, Merck & Co., Inc., Kenilworth, NJ, USA
| |
Collapse
|
21
|
Shi G, Lin L, Liu Y, Chen G, Luo Y, Wu Y, Li H. Pharmaceutical application of multivariate modelling techniques: a review on the manufacturing of tablets. RSC Adv 2021; 11:8323-8345. [PMID: 35423324 PMCID: PMC8695199 DOI: 10.1039/d0ra08030f] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2020] [Accepted: 01/26/2021] [Indexed: 11/21/2022] Open
Abstract
The tablet manufacturing process is a complex system, especially in continuous manufacturing (CM). It includes multiple unit operations, such as mixing, granulation, and tableting. In tablet manufacturing, critical quality attributes are influenced by multiple factorial relationships between material properties, process variables, and interactions. Moreover, the variation in raw material attributes and manufacturing processes is an inherent characteristic and seriously affects the quality of pharmaceutical products. To deepen our understanding of the tablet manufacturing process, multivariable modeling techniques can replace univariate analysis to investigate tablet manufacturing. In this review, the roles of the most prominent multivariate modeling techniques in the tablet manufacturing process are discussed. The review mainly focuses on applying multivariate modeling techniques to process understanding, optimization, process monitoring, and process control within multiple unit operations. To minimize the errors in the process of modeling, good modeling practice (GMoP) was introduced into the pharmaceutical process. Furthermore, current progress in the continuous manufacturing of tablets and the role of multivariate modeling techniques in continuous manufacturing are introduced. In this review, information is provided to both researchers and manufacturers to improve tablet quality.
Collapse
Affiliation(s)
- Guolin Shi
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700 China
| | - Longfei Lin
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700 China
| | - Yuling Liu
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700 China
| | - Gongsen Chen
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700 China
| | - Yuting Luo
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700 China
| | - Yanqiu Wu
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700 China
| | - Hui Li
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700 China
| |
Collapse
|
22
|
El Kassem B, Heider Y, Brinz T, Markert B. A multivariate statistical approach to analyze the impact of material attributes and process parameters on the quality performance of an auger dosing process. J Drug Deliv Sci Technol 2020. [DOI: 10.1016/j.jddst.2020.101950] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
23
|
Schenck L, Erdemir D, Saunders Gorka L, Merritt JM, Marziano I, Ho R, Lee M, Bullard J, Boukerche M, Ferguson S, Florence AJ, Khan SA, Sun CC. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Mol Pharm 2020; 17:2232-2244. [DOI: 10.1021/acs.molpharmaceut.0c00198] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Luke Schenck
- Process Research and Development, Merck & Co. Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States
| | - Deniz Erdemir
- Drug Product Development, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick New Jersey 08903, United States
| | | | - Jeremy M. Merritt
- Small Molecule Design and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46221, United States
| | - Ivan Marziano
- Pfizer R&D UK Limited, Discovery Park, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom
| | - Raimundo Ho
- Solid State Chemistry, AbbVie Inc., 1 North Waukegan Road, Chicago, Illinois 60064, United States
| | - Mei Lee
- Chemical Development, Product Development and Supply, GlaxoSmithKline, Gunnelswood Road, Stevenage SG1 2NY, United Kingdom
| | - Joseph Bullard
- Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, Massachusetts 02210, United States
| | - Moussa Boukerche
- Center of Excellence for Isolation and Separation Technologies, AbbVie Inc., 1 North Waukegan Road, Chicago, Illinois 60064, United States
| | - Steven Ferguson
- SSPC, The SFI Centre for Pharmaceuticals, School of Chemical and Bioprocess Engineering, University College Dublin, Belifield, Dublin 4, Ireland
| | - Alastair J. Florence
- EPSRC Future Continuous Manufacturing and Advanced Crystallization Hub, CMAC, University of Strathclyde Glasgow, Glasgow, United Kingdom
| | - Saif A. Khan
- Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117576, Singapore
| | - Changquan Calvin Sun
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States
| |
Collapse
|
24
|
Ervasti T, Niinikoski H, Mäki-Lohiluoma E, Leppinen H, Ketolainen J, Korhonen O, Lakio S. The Comparison of Two Challenging Low Dose APIs in a Continuous Direct Compression Process. Pharmaceutics 2020; 12:pharmaceutics12030279. [PMID: 32244950 PMCID: PMC7151305 DOI: 10.3390/pharmaceutics12030279] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 03/13/2020] [Accepted: 03/18/2020] [Indexed: 11/18/2022] Open
Abstract
Segregation is a common problem in batch-based direct compression (BDC) processes, especially with low-dose tablet products, as is the preparation of a homogenous mixture. The scope of the current work was to explore if a continuous direct compression (CDC) process could serve as a solution for these challenges. Furthermore, the principle of a platform formulation was demonstrated for low dose tablets. The combination of filler excipients and the API in the formulation used was suitable for direct compression, but also prone to induce segregation in BDC process. The CDC process was found to be very promising; it was shown that tablets with the desired quality parameters could be manufactured successfully with both of the APIs studied. Powder analysis indicated that the APIs display some fundamental differences in their physical properties, which was also reflected in powder mixture properties and, hence, eventually in processing. However, process parameters, especially mixer impeller speed, were not found to have any significant influence on end product quality. The study suggests that a CDC process can be a viable solution to resolve the challenges described. Moreover, manufacturing by using a universal platform formulation seems to be a feasible way for producing low-dose tablets.
Collapse
Affiliation(s)
- Tuomas Ervasti
- School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland; (H.N.); (J.K.); (O.K.)
- Correspondence: ; Tel.: +358403553252
| | - Hannes Niinikoski
- School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland; (H.N.); (J.K.); (O.K.)
| | | | - Heidi Leppinen
- Orion Pharma Oyj, 02200 Espoo, Finland; (E.M.-L.); (H.L.); (S.L.)
| | - Jarkko Ketolainen
- School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland; (H.N.); (J.K.); (O.K.)
| | - Ossi Korhonen
- School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland; (H.N.); (J.K.); (O.K.)
| | - Satu Lakio
- Orion Pharma Oyj, 02200 Espoo, Finland; (E.M.-L.); (H.L.); (S.L.)
| |
Collapse
|
25
|
Hsiao WK, Hörmann TR, Toson P, Paudel A, Ghiotti P, Stauffer F, Bauer F, Lakio S, Behrend O, Maurer R, Holman J, Khinast J. Feeding of particle-based materials in continuous solid dosage manufacturing: a material science perspective. Drug Discov Today 2020; 25:800-806. [PMID: 31982395 DOI: 10.1016/j.drudis.2020.01.013] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 12/17/2019] [Accepted: 01/16/2020] [Indexed: 11/16/2022]
Abstract
The pharmaceutical industry today is experiencing a paradigm shift from batch to continuous manufacturing, which promises greater flexibility to target diverse populations, as well as more-consistent product quality to ensure best efficacy. However, shifting to continuous processing means that even basic process steps, such as feeding, can become unexpected but are crucially important. In this review, we will present the fundamental differences between dispensing (batch) and feeding (continuous) and how they impact the formulation design space. We will further outline our rational development approach, applicable to continuous unit operations in general, which includes standardized material and process characterization, as well as predictive modeling based on advanced, multidomain simulation tools.
Collapse
Affiliation(s)
- Wen-Kai Hsiao
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria; European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com)
| | - Theresa R Hörmann
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria; European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); Graz University of Technology, Graz, Austria
| | - Peter Toson
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
| | - Amrit Paudel
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria; European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); Graz University of Technology, Graz, Austria
| | - Patrizia Ghiotti
- European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); UCB Pharma S.A., Brussels, Belgium
| | - Fanny Stauffer
- European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); UCB Pharma S.A., Brussels, Belgium
| | - Finn Bauer
- European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); Merck KGaA, Darmstadt, Germany
| | - Satu Lakio
- European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); Orion Pharma, Espoo, Finland
| | - Olaf Behrend
- European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
| | - Reto Maurer
- European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - James Holman
- European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); GEA Group, Wommelgem, Belgium
| | - Johannes Khinast
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria; European Consortium of Continuous Pharmaceutical Manufacturing (eccpm.com); Graz University of Technology, Graz, Austria.
| |
Collapse
|
26
|
Yu J, Xu B, Zhang K, Shi C, Zhang Z, Fu J, Qiao Y. Using a Material Library to Understand the Impacts of Raw Material Properties on Ribbon Quality in Roll Compaction. Pharmaceutics 2019; 11:pharmaceutics11120662. [PMID: 31817930 PMCID: PMC6956229 DOI: 10.3390/pharmaceutics11120662] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 11/09/2019] [Accepted: 12/04/2019] [Indexed: 12/19/2022] Open
Abstract
The purpose of this study is to use a material library to investigate the effect of raw material properties on ribbon tensile strength (TS) and solid fraction (SF) in the roll compaction (RC) process. A total of 81 pharmaceutical materials, including 53 excipients and 28 natural product powders (NPPs), were characterized by 22 material descriptors and were compacted under five different hydraulic pressures. The transversal and longitudinal splitting behaviors of the ribbons were summarized. The TS-porosity and TS-pressure relationships were used to explain the roll compaction behavior of powdered materials. Through defining the target ribbon quality (i.e., 0.6 ≤ SF ≤ 0.8 and TS ≥ 1 MPa), the roll compaction behavior classification system (RCBCS) was built and 81 materials were classified into three categories. A total of 24 excipients and five NPPs were classified as Category I materials, which fulfilled the target ribbon quality and had less occurrence of transversal splitting. Moreover, the multivariate relationships between raw material descriptors, the hydraulic pressure and ribbon quality attributes were obtained by PLS regression. Four density-related material descriptors and the cohesion index were identified as critical material attributes (CMAs). The multi-objective design space summarizing the feasible material properties and operational region for the RC process were visualized. The RCBCS presented in this paper enables a formulator to perform the initial risk assessment of any new materials, and the data modeling method helps to predict the impact of formulation ingredients on strength and porosity of compacts.
Collapse
Affiliation(s)
- Jiaqi Yu
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
| | - Bing Xu
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China; (Z.Z.); (J.F.)
- Correspondence: (B.X.); (Y.Q.); Tel.: +86-010-53912117 (B.X.)
| | - Kunfeng Zhang
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
| | - Chenfeng Shi
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
| | - Zhiqiang Zhang
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China; (Z.Z.); (J.F.)
- Beijing Tcmages Pharmceutical Co. LTD, Beijing 101301, China
| | - Jing Fu
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China; (Z.Z.); (J.F.)
- Beijing Tcmages Pharmceutical Co. LTD, Beijing 101301, China
| | - Yanjiang Qiao
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China; (Z.Z.); (J.F.)
- Correspondence: (B.X.); (Y.Q.); Tel.: +86-010-53912117 (B.X.)
| |
Collapse
|